NM_001407446.1:c.-343A>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001407446.1(APC):​c.-343A>G variant causes a upstream gene change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0704 in 339,774 control chromosomes in the GnomAD database, including 1,122 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.068 ( 490 hom., cov: 33)
Exomes 𝑓: 0.072 ( 632 hom. )

Consequence

APC
NM_001407446.1 upstream_gene

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -1.48

Publications

4 publications found
Variant links:
Genes affected
APC (HGNC:583): (APC regulator of WNT signaling pathway) This gene encodes a tumor suppressor protein that acts as an antagonist of the Wnt signaling pathway. It is also involved in other processes including cell migration and adhesion, transcriptional activation, and apoptosis. Defects in this gene cause familial adenomatous polyposis (FAP), an autosomal dominant pre-malignant disease that usually progresses to malignancy. Mutations in the APC gene have been found to occur in most colorectal cancers, where disease-associated mutations tend to be clustered in a small region designated the mutation cluster region (MCR) and result in a truncated protein product. [provided by RefSeq, Jun 2022]
APC Gene-Disease associations (from GenCC):
  • classic or attenuated familial adenomatous polyposis
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • desmoid tumor
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp
  • familial adenomatous polyposis 1
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • gastric adenocarcinoma and proximal polyposis of the stomach
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen, Orphanet
  • sarcoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • APC-related attenuated familial adenomatous polyposis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Turcot syndrome with polyposis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Cenani-Lenz syndactyly syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 5-112707375-A-G is Benign according to our data. Variant chr5-112707375-A-G is described in ClinVar as Benign. ClinVar VariationId is 386417.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0953 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
APCNM_001407446.1 linkc.-343A>G upstream_gene_variant NP_001394375.1
APCNM_001407447.1 linkc.-526A>G upstream_gene_variant NP_001394376.1
APCNM_001407448.1 linkc.-293A>G upstream_gene_variant NP_001394377.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
APCENST00000509732.6 linkc.-293A>G upstream_gene_variant 4 ENSP00000426541.2 D6RFL6
APCENST00000507379.6 linkc.-343A>G upstream_gene_variant 2 ENSP00000423224.2 A0A2Q2SV78
APCENST00000505350.2 linkn.-343A>G upstream_gene_variant 3 ENSP00000481752.1 A0A087WYF3
APCENST00000713636.1 linkn.-526A>G upstream_gene_variant ENSP00000518937.1

Frequencies

GnomAD3 genomes
AF:
0.0679
AC:
10333
AN:
152282
Hom.:
487
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0178
Gnomad AMI
AF:
0.151
Gnomad AMR
AF:
0.0632
Gnomad ASJ
AF:
0.107
Gnomad EAS
AF:
0.000576
Gnomad SAS
AF:
0.0207
Gnomad FIN
AF:
0.115
Gnomad MID
AF:
0.0728
Gnomad NFE
AF:
0.0972
Gnomad OTH
AF:
0.0735
GnomAD4 exome
AF:
0.0724
AC:
13568
AN:
187374
Hom.:
632
AF XY:
0.0690
AC XY:
6585
AN XY:
95392
show subpopulations
African (AFR)
AF:
0.0181
AC:
123
AN:
6788
American (AMR)
AF:
0.0533
AC:
420
AN:
7886
Ashkenazi Jewish (ASJ)
AF:
0.102
AC:
721
AN:
7040
East Asian (EAS)
AF:
0.000200
AC:
3
AN:
14964
South Asian (SAS)
AF:
0.0264
AC:
631
AN:
23906
European-Finnish (FIN)
AF:
0.0843
AC:
521
AN:
6182
Middle Eastern (MID)
AF:
0.0919
AC:
79
AN:
860
European-Non Finnish (NFE)
AF:
0.0938
AC:
10133
AN:
107984
Other (OTH)
AF:
0.0796
AC:
937
AN:
11764
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
607
1214
1820
2427
3034
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0679
AC:
10346
AN:
152400
Hom.:
490
Cov.:
33
AF XY:
0.0667
AC XY:
4968
AN XY:
74530
show subpopulations
African (AFR)
AF:
0.0178
AC:
740
AN:
41608
American (AMR)
AF:
0.0631
AC:
966
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.107
AC:
371
AN:
3472
East Asian (EAS)
AF:
0.000578
AC:
3
AN:
5194
South Asian (SAS)
AF:
0.0215
AC:
104
AN:
4834
European-Finnish (FIN)
AF:
0.115
AC:
1224
AN:
10626
Middle Eastern (MID)
AF:
0.0680
AC:
20
AN:
294
European-Non Finnish (NFE)
AF:
0.0972
AC:
6614
AN:
68032
Other (OTH)
AF:
0.0784
AC:
166
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
540
1080
1620
2160
2700
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
118
236
354
472
590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0625
Hom.:
161
Bravo
AF:
0.0634
Asia WGS
AF:
0.0420
AC:
145
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Nov 16, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Familial adenomatous polyposis 1 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

APC-related disorder Benign:1
May 04, 2023
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
0.24
DANN
Benign
0.70
PhyloP100
-1.5
PromoterAI
-0.040
Neutral

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs13180781; hg19: chr5-112043072; API